May 31, 2016
"So we have FLACS, this new technology that has shown steady improvement and that many support. Yet others feel its advantages are either clinically unimportant or lack convincing clinical studies to support uniform utilization in the face of increased expense and time. While this wave is far from peaking, it would seem that supporters of FLACS are remiss in not providing more robust comparative studies, especially looking at any complication differences in the very difficult cataract categories. Although the jury may be out, I think many cataract surgeons are underwhelmed with FLACS supplanting phaco alone as today's dominant cataract removal procedure. That said, future studies and/or technology advancement may change this view."
What Exactly Does Femtosecond Technology Add to Phacoemulsification Based on Objective Studies To Date?
Randall J. Olsoncorrespondenceemail
Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah